Articles

Ingredients of Vicks VapoRub inhibit rhinovirus-induced ATP release

Rebecca J Stinson, Alyn H Morice, Basir Ahmad, Laura R Sadofsky

Article Type

Original Research

Published

This article suggests that some Vicks VapoRub ingredients may reduce symptoms associated with upper respiratory tract infection by modulating specific TRP receptors and by reducing RV16-induced ATP release.

Read more

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Alejandro Bimbo Diaz, Jeremy Chow, Fan Kee Hoo, Kok Wei Koh, Gary Chin Keong Lee, Wee Siong Teo, Narayanaswamy Venketasubramanian, Chun-Chieh Wang, Radhika Mehta

Article Type

Case Series

Published

The authors share early clinical experiences with once-daily edoxaban and discuss its evidence-based use in patients with non-valvular atrial fibrillation in Southeast Asia through several cases of patients at high risk

Read more

Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system

Guido Mannaioni, Fabio Lugoboni

Article Type

Review

Published

This articles aims is to provide useful information and insights for the management of opioid agonist therapy by providing an overview that ranges from the characteristics of opioid use disorder patients to the macroscopic phenomena of social-health significance on a national scale, with a particular focus on the Italian territory.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.